Dicerna Pharmaceuticals

Dicerna Pharmaceuticals

Verified

Financials

Edit
Revenues, earnings & profits over time
USD2016201720182019202020212022E
Revenues-1m6m23m164m193m191m
% growth--500 %283 %613 %18 %(1 %)
EBITDA-(50m)(60m)(127m)(111m)(142m)(213m)
% EBITDA margin-(5000 %)(1000 %)(552 %)(68 %)(74 %)(112 %)
Profit-(60m)(88m)(120m)(113m)(127m)(149m)
% profit margin-(6000 %)(1467 %)(522 %)(69 %)(66 %)(78 %)
EV / revenue-466.0x111.8x51.4x6.9x--
EV / EBITDA--9.3x-11.2x-9.3x-10.2x--
R&D budget39.6m28.6m35.2m78.1m---
R&D % of revenue-2860 %587 %340 %---

Source: Company fillings or news article

  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
$8.4mSeries A
$124mEarly VC
N/A$29.1mSeries B
$4mSeries B
$60mSeries C
N/AN/AIPO
$70mPost IPO Equity
N/A$100mPost IPO Equity
*
$3.3b
Valuation: $3.3b
Acquisition
Total Funding$226m

Recent News about Dicerna Pharmaceuticals

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.